Company News, Financial News

Pfizer To Acquire Allergan

$160 billion deal will merge two industry leaders.


By: Melissa Meisel

Pfizer To Acquire Allergan

Botox is big business! Botox maker Allergan will merge with Pfizer in a record-breaking deal worth $160 billion. Allergan CEO Brent Saunders will be president and chief operating officer, while Pfizer Chief Executive Officer Ian Read will maintain his position.

“The combination of Allergan and Pfizer is a highly strategic, value-enhancing transaction that brings together two biopharma powerhouses to change lives for the better,” said Saunders. “This bold action is the next chapter in the successful transformation of Allergan allowing us to operate with greater resources at a much bigger scale. Joining forces with Pfizer matches our leading products in seven high growth therapeutic areas and our robust R&D pipeline with Pfizer’s leading innovative and established businesses, vast global footprint and strength in discovery and development research to create a new biopharma leader.”

Under the terms of the proposed transaction, the businesses of Pfizer and Allergan will be combined under Allergan plc, which will be renamed “Pfizer plc.” The companies expect that shares of the combined company will be listed on the New York Stock Exchange and trade under the “PFE” ticker.

Keep up with the story. Subscribe to the Happi free daily

Related Breaking News